Interv Akut Kardiol. 2005;4(2):98-102

COMPLICATED CORONARY INTERVENTIONS. WHEN IS EARLY ENOUGH? WHEN IS TOO LATE?

Josef Šťásek4, Dušan Černohorský1, Josef Bis3, Miroslav Brtko2, Pavel Polanský2, Jan Vojáček3,4
1 Klinika gerontologická a metabolická, FN Hradec Králové
2 Kardiochirurgická klinika LF UK a Kardiocentrum FN Hradec Králové
3 I. interní klinika Fakultní nemocnice v Hradci Králové
4 Kardiocentrum dospělých, oddělení invazivní kardiologie interní kliniky 2. LF UK a FN Motol, Praha

The authors discuss the issue of complex coronary interventions in high risk patients on an example of four case reports. In this group of patients, it is possible to perform PCI successfully, but a higher incidence of serious complications has to be taken into account. The authors claim that new systems of circulation support might improve the outcomes of high risk PCI.

Keywords: Key words: high risk PCI, complex coronary lesion.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šťásek J, Černohorský D, Bis J, Brtko M, Polanský P, Vojáček J. COMPLICATED CORONARY INTERVENTIONS. WHEN IS EARLY ENOUGH? WHEN IS TOO LATE? Interv Akut Kardiol. 2005;4(2):98-102.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Briguori C, Sarais C, Pagnotta P, et all. Elective vervus provisional baloon pumping in high risk percutaneous transluminal coronaroplasty. Am Heart J 2003; 145: 700-707. Go to original source... Go to PubMed...
    2. de Feyter PJ, Ruygrok PN. Coronary intervention: risk stratification and management of abrupt coronary occlusion. Eur Heart J 1995; 16: 97-103. Go to original source... Go to PubMed...
    3. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstabel angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360: 743-751. Go to original source... Go to PubMed...
    4. Grüntzig A. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1: 263. Go to original source... Go to PubMed...
    5. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Fragmin and Fast Revascularisation during InStability in coronary artery disease Investigators. Lancet 1999; 354: 708-715.
    6. Kimura A, Toyota E, Sonfrang L, et al. Effects of intraaortic baloon pumping on the septal arterial blood flow velocity wavefrom during severe left main coronary artery stenosis. J Am Coll Cardiol 1996; 27: 810-816. Go to original source... Go to PubMed...
    7. Lemos PA, Cummins P, Lee CH, et al. Usufuless of percutaneous left ventricular assistence to support high risk pertucaneous coronary interventions. Am J Cardiol 2003; 91: 479-481. Go to original source... Go to PubMed...
    8. McCullough PA, O´Neill WW, Graham M, et al. A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exlusion (MATE) trial. J Am Coll Cardiol 1998; 32: 596-605. Go to original source... Go to PubMed...
    9. Menon V, Slater JN, Whitw ED, et al. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOK Trial Registy. Am J Med 2000; 108: 374 380. Go to original source... Go to PubMed...
    10. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323. Go to original source... Go to PubMed...
    11. Moussa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999; 99: 2364-2366. Go to original source... Go to PubMed...
    12. Park SJ, Shim WH, Ho DS, et al. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003; 348: 1537-1545. Go to original source... Go to PubMed...
    13. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Plateler IIb/IIIa Inhibitor for Stenting. Lancet 1998; 352: 87-92.
    14. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study Lancet 1997; 349: 1429-1435.
    15. Savage MP, Douglas JS Jr, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Sphenous Vein De Novo Trial Investigators. N Engl J Med 1997; 337: 740-747. Go to original source... Go to PubMed...
    16. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 1998; 352: 673-681. Go to original source... Go to PubMed...
    17. Serruys PW, et al. Stenting vs CABG in multivessel coronary artery disease. ARTS trial. N Engl J Med 2001; 344: 1117-1124. Go to original source... Go to PubMed...
    18. Singh M, Lennon RJ, Holmes DR, et al. Correlation of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002; 40: 387-393. Go to original source... Go to PubMed...
    19. Singh M, Rihal CS, Selzer F, et al. Validation of Mayo Clinic Risk adjustment model for in hospital complication after pertcutaneou coronary interventions, using the National Heart Lung and blood institute dynamic registry. J Am Coll Cardiol 2003; 42: 1722-1728. Go to original source... Go to PubMed...
    20. Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon contrapulzatino in acute myocardial infarction: the Benchmarkt Registry. J Am Coll Cardiol 2003; 41: 1940-1945. Go to original source... Go to PubMed...
    21. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutanous coronary revascularization N Engl J Med 1997; 336: 1689-1696. Go to original source... Go to PubMed...
    22. Vranckx P, Foley PD, de Feyter PJ, et al. Clinical introduction of the Tandemheart a percutaneous left ventricular assist device, for cilculatory support during high risk percutaneous coronary intervention. Int J Cardiovascular Interventions, 2003; 5: 35-39. Go to original source... Go to PubMed...
    23. Widimský P, Groch L, Želízko M, et al. Multicenter randomized trial comparing transport to primary angioplasty vs. Immediate thrombolysis vs. Combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur Heart J 2000; 21: 823-831. Go to original source... Go to PubMed...
    24. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-1419. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.